<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Rev Bras Ter Intensiva</journal-id>
      <journal-id journal-id-type="iso-abbrev">Rev Bras Ter Intensiva</journal-id>
      <journal-title-group>
        <journal-title>Revista Brasileira de Terapia Intensiva</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0103-507X</issn>
      <issn pub-type="epub">1982-4335</issn>
      <publisher>
        <publisher-name>Associa&#xE7;&#xE3;o Brasileira de Medicina
intensiva</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25607275</article-id>
      <article-id pub-id-type="pmc">4304474</article-id>
      <article-id pub-id-type="doi">10.5935/0103-507X.20140066</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Venous sinus thrombosis in a child with nephrotic syndrome: a case report
and literature review</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Trombose de seios venosos em crian&#xE7;a com s&#xED;ndrome
nefr&#xF3;tica: relato de caso e revis&#xE3;o da literatura</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Torres</surname>
            <given-names>Ronaldo Afonso</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="aff" rid="aff02">2</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Torres</surname>
            <given-names>Bruna Ribeiro</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Castilho</surname>
            <given-names>Alessandra Soares Rocha</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Honorato</surname>
            <given-names>Ronaldo</given-names>
          </name>
          <xref ref-type="aff" rid="aff05">5</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label>Neonatal and Pediatric Intensive Care Unit, Hospital Santa Isabel -
Ub&#xE1; (MG), Brazil.</aff>
      <aff id="aff02"><label>2</label>Department of Medicine and Nursing, Universidade Federal de
Vi&#xE7;osa - Vi&#xE7;osa (MG), Brazil.</aff>
      <aff id="aff03"><label>3</label>Academic Course of Medicine, Faculdade de Ci&#xEA;ncias M&#xE9;dicas
e da Sa&#xFA;de de Juiz de Fora - SUPREMA - Juiz de Fora (MG), Brazil.</aff>
      <aff id="aff04"><label>4</label>Children&#x2019;s Nephrology Service, Hospital Santa Isabel - Ub&#xE1; (MG),
Brazil.</aff>
      <aff id="aff05"><label>5</label>Radiology Service, Hospital Santa Isabel - Ub&#xE1; (MG),
Brazil.</aff>
      <author-notes>
        <corresp id="c01"><bold>Corresponding author:</bold> Ronaldo Afonso Torres, Rua Frei
Corn&#xE9;lio, 200 - Laurindo de Castro, Zip code: 36500-000 - Ub&#xE1; (MG),
Brazil. E-mail: <email>ronaldo.torres@ufv.br</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Oct-Dec</season>
        <year>2014</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Oct-Dec</season>
        <year>2014</year>
      </pub-date>
      <volume>26</volume>
      <issue>4</issue>
      <fpage>430</fpage>
      <lpage>434</lpage>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>6</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>11</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>Nephrotic syndrome is associated with a hypercoagulable state and an increased risk
of thromboembolic complications. Cerebral venous sinus thrombosis is a rare
complication of nephrotic syndrome, with few cases described in the literature,
although the disease may be under-diagnosis. The true incidence of cerebral venous
sinus thrombosis may be underestimated because many events are asymptomatic or are
not diagnosed in time. Here, we describe the case of a male child, 2 years and 10
months old, with nephrotic syndrome presenting with headache, epileptic seizures and
sensory inhibition who was diagnosed with superior sagittal and transverse sinuses
thrombosis. An international literature review was performed with a defined search
strategy in the PubMed, SciELO and Lilacs databases using the terms &#x2018;nephrotic
syndrome&#x2019; and &#x2018;cerebral sinovenous thrombosis&#x2019;. The diagnosis of venous thrombosis
should be considered in any patient with nephrotic syndrome who presents with
neurological signs and symptoms, as early clinical diagnosis promotes favorable
outcomes.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>A s&#xED;ndrome nefr&#xF3;tica associa-se a um estado de hipercoagulabilidade,
apresentando risco aumentado de complica&#xE7;&#xF5;es tromboemb&#xF3;licas. A
trombose dos seios venosos cerebrais &#xE9; uma complica&#xE7;&#xE3;o rara da
s&#xED;ndrome nefr&#xF3;tica, com poucos casos descritos na literatura, mas com
diagn&#xF3;sticos cada vez mais frequentes. A verdadeira incid&#xEA;ncia pode
estar subestimada, uma vez que muitos eventos s&#xE3;o assintom&#xE1;ticos ou
n&#xE3;o s&#xE3;o diagnosticados a tempo. Descrevemos aqui o caso de uma
crian&#xE7;a do sexo masculino, de 2 anos e 10 meses, com s&#xED;ndrome
nefr&#xF3;tica, que apresentou, na evolu&#xE7;&#xE3;o, cefaleia, crises
epil&#xE9;pticas e rebaixamento sensorial, com o diagn&#xF3;stico de trombose do
seio sagital superior e transverso. Foi realizada revis&#xE3;o da literatura
internacional por meio de estrat&#xE9;gia de busca definida, nas bases de dados
PubMed, SciELO e Lilacs, utilizando os termos &#x201C;<italic>nephrotic syndrome</italic>&#x201D; e
&#x201C;<italic>cerebral sinovenous thrombosis</italic>&#x201D;. O diagn&#xF3;stico de
trombose venosa deve ser considerado em qualquer paciente com s&#xED;ndrome
nefr&#xF3;tica que manifeste sinais e sintomas neurol&#xF3;gicos, destacando que
a suspeita cl&#xED;nica precoce tem rela&#xE7;&#xE3;o com um desfecho
favor&#xE1;vel.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Sinus thrombosis, intracranial/etiology</kwd>
        <kwd>Venous thrombosis</kwd>
        <kwd>Nephrotic syndrome/complications</kwd>
        <kwd>Child</kwd>
        <kwd>Case reports</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Nephrotic syndrome (NS) is associated with a hypercoagulable state due to the increase
in the plasma levels of fibrinogen and coagulation factors V and VIII, urinary loss of
antithrombin III, changes in the fibrinolytic system, thrombocytosis and increased
platelet activation and aggregation. The incidence of thromboembolic complications in
children with NS varies between 2 and 5% and is less than in adults. The age
distribution of NS subtypes explains this difference; membranous nephropathy
predominates among adults and is more associated with thromboembolic events; minimal
lesion NS predominates among children and presents a lower risk of those outcomes.
Thrombosis can be venous or arterial, although arterial events are less commonly
associated with NS. The most frequently affected vessels include the renal vein, the
pulmonary artery, the deep veins of the lower limbs, the inferior vena cava and the
femoral artery.<sup>(<xref rid="r01" ref-type="bibr">1</xref>-<xref rid="r07" ref-type="bibr">7</xref>)</sup></p>
      <p>In conjunction with an international literature review using defined search strategy in
the PubMed, SciELO and Lilacs databases with the terms &#x2018;nephrotic syndrome&#x2019; and
&#x2018;cerebral sinovenous thrombosis&#x2019;, the discussion of this case emphasizes that early
diagnosis of thromboembolytic syndrome in NS is crucial to the introduction of
anticoagulant therapy and good prognosis.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>Informed consent to present this case report was obtained from the responsible
parties.</p>
      <p>A 34-month-old Caucasian male child with a 1-month history of NS treated by
corticotherapy with prednisolone associated with loop diuretics (furosemide) was
admitted in the pediatric intensive care unit (PICU) of the <italic>Hospital Santa
Isabel</italic> in Ub&#xE1; (MG) from Emergency Services. Upon hospital admission,
the patient exhibited headache, vomiting and liquid diarrhea of 48-hour duration with
sensory loss. The day of admission, the child experience subintrant generalized
tonic-clonic convulsive seizures. The mother reported recent use of azithromycin to
treat an upper respiratory tract infection. On physical examination, the child exhibited
pallor, borderline dehydration, arterial hypertension, photoreactive pupil, edema ++/4+,
and no signs of meningeal irritation. Venous access was obtained, and diphenylhydantoin
and continuous infusion of midazolam were administered. Laboratory exams revealed
leukocytosis (global leukocytes: 28,000/mm<sup>3</sup>), hypoalbuminemia (2.1g/dL), a
normal ionogram and C-reactive protein (CRP) of 25.9mg/dL (reference value: up to
6mg/dL). We chose to collect cephalorachidian liquor, which revealed hyperproteinorachia
(67mg/dL; reference values: 15 to 40mg/dL), cellularity, normal cytometry and
glycorrhachia. Cerebral magnetic resonance imaging was conducted, which revealed an
image compatible with superior sagittal sinus and transverse sinus thrombosis, largely
restricted to the left hemisphere (<xref ref-type="fig" rid="f01">Figure 1</xref>).
Sagittal, axial and coronal planes at T1, T2, T2* and Flair sequences revealed the
presence of a hypointense lesion on T1 and a hyperintense lesion on T2 inside the
superior sagittal sinus and the left transverse sinus, suggesting thrombosis in both
sinuses. There was no enhancement of pathologic area after the injection of
contrast.</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Sagittal view in T1-weighted sequence.</p>
        </caption>
        <graphic xlink:href="rbti-26-04-0430-g01"/>
      </fig>
      <p>Once the radiologic diagnosis was established, treatment for cerebral venous thrombosis
(CVT) began with a continuous infusion of intravenous heparin. The use of corticosteroid
was maintained, and loop diuretics were stopped. The patient required a gradual increase
of heparin up to 35UI/kg/hour because of the mild effect on the partial thromboplastin
time. When midazolam was removed, we observed hazy mydriasis without focal signs or loss
of muscle strength. Ophthalmic examination revealed optic papilla with physiologic
excavation and mild to moderate blurred edges, which was consistent with mild to
moderate papillitis. Routine exams reveal the persistence of hypoalbuminemia and massive
proteinuria, and three cycles of methylprednisolone pulse therapy were administered.
Reduced proteinuria and increased serum albumin were initially observed with pulse
therapy but were accompanied by rapid relapse of the nephrotic framework. With the onset
of fever, chills, incoercible vomiting and cyanosis of the extremities, new exams were
conducted, revealing anemia (hemoglobin: 9.7g/dL; reference values: 11.5 to 13.5g/dL),
leukocytosis with left shift (19,600/mm<sup>3</sup>) and CRP of 23.1mg/L. Antimicrobial
therapy for hospital-acquired infection with ceftazidime (150mg/kg/day) and vancomycin
(40mg/kg/day) began, with a gradual improvement in the infection response. Once
improvements in nephrotic syndrome ceased, cyclophosphamide treatment was started, which
improved the proteinuria and reduced the edema. Phenobarbital was also administered, and
diphenylhydantoin was progressively reduced. The patient was discharged from intensive
treatment after 45 days of hospitalization for ambulatory care in pediatric nephrology
and ophthalmology because of poor visual acuity. The patient experienced no relapses of
the nephrotic syndrome for 8 months after hospitalization but experienced three relapses
after this period and recurrent proteinuria. Histopathology of the renal biopsy was
compatible with minimal glomerular lesions. Currently, the patient exhibits good renal
function without proteinuria. From the neurological point of view, he exhibits
appropriate neuro-psychomotor development without focal changes. The patient experiences
poor visual acuity and regularly uses glasses.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>NS, a glomerular disease that mostly affects children, is classically defined by massive
proteinuria (&gt;40mg/m<sup>2</sup>/hour), hypoalbuminemia (&lt;2.5g/dL), generalized
edema and hyperlipidemia. NS complications can occur as part of the course of disease or
as a consequence of the pharmacological treatment. Among the complications associated
with the disease, CVT is an unusual condition, with few reports and case series
described in the literature, especially among children. However, the recent increase in
the number of cases may indicate that NS has been underdiagnosed in the past.<sup>(<xref rid="r01" ref-type="bibr">1</xref>-<xref rid="r10" ref-type="bibr">10</xref>)</sup></p>
      <p>Considering all possible etiologies, CVT has an incidence of 0.67 cases per 100 thousand
children per year, i.e., it is likely underestimated. The exact incidence of CVT
associated with NS is unknown, but CVT is believed to represent 4.7 to 6% of all CVT
cases in children, excluding newborns. CVT involves the thrombosis of the intracranial
venous sinus and cerebral veins, which leads to impaired venous drainage and, thus,
intracranial hypertension and/or venous infarction. Because of the highly variable
clinical presentation and because the disease is relatively uncommon in pediatric
patients, the diagnosis of CVT is difficult, delayed or missed in some cases. The low
incidence contributes to our poor understanding of the source and physiopathology of CVT
in pediatric patients. Risk factors for CVT vary by age and frequently different in
number and quality between children and adults. Infections are the most common factor in
newborns as well as in older children, followed by hypercoagulable states and
dehydration. Most of the cases arise from a combination of prothrombotic risk factors
with or without subjacent clinical condition.<sup>(<xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r11" ref-type="bibr">11</xref>-<xref rid="r17" ref-type="bibr">17</xref>)</sup></p>
      <p>NS is a known risk factor for arterial or venous thromboembolism (TE), and patients with
severe proteinuria exhibit a 3.4-fold increased risk of venous thrombosis. Thrombosis
risk is higher at the onset of NS and during relapses because of the loss of coagulation
factors and acute intravascular volume depletion during this phase of the disease. The
risk is also higher in corticoresistant NS compared with corticosensitive NS. Thrombosis
can occur in NS due to the loss of proteins involved in systemic hemostasis inhibition,
the increase in the synthesis of prothrombotic factors, or the local activation of the
glomerular hemostatic system. TE-predisposing factors in NS include the following:
anomalies in platelet activation and aggregation; coagulation system activation;
increased synthesis of coagulation factors V, VII, VIII, and X as well as von Willebrand
factor, fibrinogen, and accumulation of &#x3B1;2-macroglobulin; reduction of
endogenous anticoagulants (antithrombin III, C protein and S protein); decreased
activity of the fibrinolytic system and imbalance of the plasmin formation system;
changes in the glomerular hemostatic system; intravascular volume depletion; and the use
of diuretics.<sup>(<xref rid="r01" ref-type="bibr">1</xref>-<xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r06" ref-type="bibr">6</xref>,<xref rid="r07" ref-type="bibr">7</xref>,<xref rid="r09" ref-type="bibr">9</xref>,<xref rid="r11" ref-type="bibr">11</xref>-<xref rid="r15" ref-type="bibr">15</xref>)</sup></p>
      <p>Considering the factors involved in the genesis of the thromboembolic framework, caution
should be taken in the use of diuretics in NS because the treatment enhances hypovolemia
in nephrotic patients, thereby increasing the risk for TE. The clinical manifestations
of CVT are nonspecific and vary with age. Convulsive seizures (generalized or focal) are
the most common presentation among newborns and children. Focal signs and neurological
symptoms, such as decreased consciousness, nausea, vomiting, motor deficits (hemiplegia
and ataxia), headache and visual changes (diplopia and papilledema), are more commonly
found in children. Among the less frequent symptoms are vertigo, somnolence, confusion
and neck pain. Because CVT symptoms are nonspecific, the disease requires a high degree
of clinical suspicion.<sup>(<xref rid="r02" ref-type="bibr">2</xref>-<xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r08" ref-type="bibr">8</xref>,<xref rid="r10" ref-type="bibr">10</xref>-<xref rid="r14" ref-type="bibr">14</xref>)</sup></p>
      <p>In the case reported, the patient exhibited with seizure, sensory deficits, headache,
vomiting and visual alterations. The child had been taking oral furosemide associated
with corticotherapy. Special care must be taken when administering diuretics in NS;
diuretics may be used in symptomatic treatment of edema in massive anasarca patients
with difficulty breathing, cellulitis refractory to antimicrobial and corticoresistant
children. Because the patient did not exhibit these conditions and because of the
possible drug influence on CVT genesis, the use of furosemide was discontinued.</p>
      <p>The key to a neuroradiology diagnosis is a high clinical suspicion index in the acute
phase; imaging must be performed early because the venous sinuses may recanalize. The
superficial venous system (SVS) is affected more frequently than the deep venous system
(DVS), and the more common sites of CVT are the sagittal, superior transversal, sigmoid
and straight sinuses. The less frequent involvement of the SVP may reflect the current
difficulty in diagnosing CVT in this system, which may demand conventional angiograms.
The diagnosis is established by demonstrating the lack of blood flow in the cerebral
veins with or without typical images of cerebral infarction on brain CT, which is
generally the first exam performed in the emergency department. Cerebral vein thrombi
can be directly visualized in cerebral CT; the initial and transitory hyperdensity of a
thrombus (called &#x2018;cord sign&#x2019;) is followed by hypodensity, producing a filling defect
(called &#x2018;empty triangle&#x2019; or empty delta sign&#x2019;). The images obtained from magnetic
resonance imaging offer better cerebral anatomy and parenchymal lesions and represent
the method of choice to establish the diagnosis of CVT. The cerebral venous flow and the
drainage of the cephalorachidian liquor are intimately related; every CVT case exhibits
varying levels of increased intracranial pressure, and headache and papilledema are
typical manifestations in older children.<sup>(<xref rid="r02" ref-type="bibr">2</xref>-<xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r07" ref-type="bibr">7</xref>-<xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r19" ref-type="bibr">19</xref>)</sup></p>
      <p>Treatment of CVT is based on symptomatic and supportive measures. As in any emergency,
airway, breathing and circulation management are imperative. Benzodiazepine therapy is
the first line of treatment of seizures in CVT. The treatment of choice is the use of
heparin followed by oral anticoagulants. Difficulty in achieving anticoagulation is
describe in NS-associated cases due to antithrombin III urinary loss.<sup>(<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r20" ref-type="bibr">20</xref>)</sup></p>
      <p>In the present case report, there was a need to gradually increase the heparin dose due
to insufficient effects on the partial thromboplastin time, which was maintained during
the acute phase, followed by oral anticoagulant throughout the remainder of the
treatment and during relapses. Oral anticoagulants have similar results but exhibit less
frequent adverse effects. The treatment of choice is hypocoagulation with non-fractional
heparin or low-molecular weight heparin (LMWH) for 5 to 7 days, followed by LMWH or a
vitamin K antagonist for 3 to 6 months or as long as the patient exhibits nephrotic
proteinuria (albumin level &lt;2g/dL) or both.</p>
      <p>Prophylactic hypocoagulation is controversial; however, prophylactic hypocoagulation
should be administered in a patient with a thromboembolic event and high risk of
recurrence based on an albumin concentration &lt;2g/dL, fibrinogen &gt;6g/L or an
antithrombin III level &lt;70% of the normal value.<sup>(<xref rid="r06" ref-type="bibr">6</xref>,<xref rid="r11" ref-type="bibr">11</xref>)</sup></p>
      <p>Long-term neurological sequelae, in descending order of frequency, are as follows: motor
deficits (hypotonia, hemiplegia and hemiparesis), seizures, cognitive dysfunction,
developmental and/or speech delay, and visual disturbances. Children who develop CVT in
the neonatal period exhibit normal intellectual abilities. However, a considerable
number exhibit a heterogeneous cognitive profile, with partial cognitive disorders. This
finding may indicate that although intellectual functioning is generally normal,
children with CVT may suffer from attention and perception disorders that are only
evident during alphabetization. The occurrence of venous infarctions, seizures, Glasgow
scale &lt;12 at admission and the presence of cerebral parenchyma lesions are associated
with a worse prognosis. A European cohort study published in 2007 associated a higher
risk of CVT recurrence with four factors: age over 2 years; absence of secondary
anticoagulant prophylaxis; absence of recanalization; and the presence of G20210A
mutation in factor II. Two cohort studies described the recurrence of symptoms in 12 to
13% of 180 long-term survivors, occurring on average 12 to 18 months after initial
presentation.<sup>(<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r21" ref-type="bibr">21</xref>,<xref rid="r22" ref-type="bibr">22</xref>)</sup></p>
      <p>The patient of this report had low visual acuity as the only sequelae. He did not
experience other CVT events and was administered an oral anticoagulant during NS
relapses. A multidisciplinary approach to CVT in NS is imperative and must include
pediatric neurology monitoring, ophthalmology and, when indicated, rehabilitative
therapy.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>CONCLUSION</title>
      <p>Cerebral venous thrombosis should be considered in any patient with nephrotic syndrome
who presents with neurological signs or symptoms. When suspected, imaging exams should
be promptly conducted. Upon confirmation of cerebral venous thrombosis, anticoagulant
therapy should be started immediately. Importantly, early clinical suspicion is
correlated with a more favorable outcomes.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p><bold>Conflicts of interest:</bold> None.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>Responsible editor:</bold> Werther Brunow de Carvalho</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>JI</given-names>
            </name>
          </person-group>
          <article-title>Complications of nephrotic syndrome</article-title>
          <source>Korean J Pediat</source>
          <year>2011</year>
          <volume>54</volume>
          <issue>8</issue>
          <fpage>322</fpage>
          <lpage>328</lpage>
          <comment>Erratum in: Korean J Pediatr. 2012;55(4):151</comment>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodrigues</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Zardini</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>de Andrade</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Mangia</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Carvalhaes</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Vilanova</surname>
              <given-names>LC</given-names>
            </name>
          </person-group>
          <article-title>Cerebral sinovenous thrombosis in a nephrotic child</article-title>
          <source>Arq Neuropsiquiatr</source>
          <year>2003</year>
          <volume>61</volume>
          <issue>4</issue>
          <fpage>1026</fpage>
          <lpage>1029</lpage>
          <pub-id pub-id-type="pmid">14762612</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pillekamp</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hoppe</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Querfeld</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Vomiting, headache and seizures in a child with idiopathic nephrotic
syndrome</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>1997</year>
          <volume>12</volume>
          <issue>6</issue>
          <fpage>1280</fpage>
          <lpage>1281</lpage>
          <pub-id pub-id-type="pmid">9198072</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bhoobun</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jalloh</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Jacobsen</surname>
              <given-names>KH</given-names>
            </name>
          </person-group>
          <article-title>Cerebral venous thrombosis in a child with nephrotic syndrome: case
report</article-title>
          <source>Pan Afr Med J</source>
          <year>2012</year>
          <volume>13</volume>
          <fpage>57</fpage>
          <pub-id pub-id-type="pmid">23346271</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meirelles</surname>
              <given-names>PZ</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Carneiro</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Koch</surname>
              <given-names>VH</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Peculiaridades da terapia trombol&#xED;tica na
s&#xED;ndrome nefr&#xF3;tica pedi&#xE1;trica: monitoriza&#xE7;&#xE3;o do
fator anti-Xa</article-title>
          <source>Rev Paul Pediatr</source>
          <year>2008</year>
          <volume>26</volume>
          <issue>2</issue>
          <fpage>183</fpage>
          <lpage>187</lpage>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Balona</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Marques</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Vilarinho</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Trombose dos seios venosos cerebrais em crian&#xE7;a
com s&#xED;ndrome nefr&#xF3;tica: caso cl&#xED;nico</article-title>
          <source>Nascer e Crescer</source>
          <year>2009</year>
          <volume>18</volume>
          <issue>2</issue>
          <fpage>85</fpage>
          <lpage>88</lpage>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zaki</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Shanbag</surname>
              <given-names>p</given-names>
            </name>
          </person-group>
          <article-title>Persistent headache in a child with the nephrotic
syndrome</article-title>
          <source>Saudi J Kidney Dis Transpl</source>
          <year>2010</year>
          <volume>21</volume>
          <issue>5</issue>
          <fpage>951</fpage>
          <lpage>953</lpage>
          <pub-id pub-id-type="pmid">20814141</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Menascu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lotan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ben Zeev</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Nowak-Goottl</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Kenet</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Cerebral venous thrombosis in the Mediterranean area in
children</article-title>
          <source>Mediterr J Hematol Infect Dis</source>
          <year>2011</year>
          <volume>3</volume>
          <issue>1</issue>
          <elocation-id/>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al Fakeeh</surname>
              <given-names>KN</given-names>
            </name>
            <name>
              <surname>Al Rasheed</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>Cerebral venous thrombosis in the nephrotic syndrome</article-title>
          <source>Saudi J Kidney Dis Transpl</source>
          <year>2000</year>
          <volume>11</volume>
          <issue>1</issue>
          <fpage>59</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">18209301</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>deVeber</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Andrew</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bjornson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Booth</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Buckley</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Camfield</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>David</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Humphreys</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Langevin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>MacDonald</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Gillett</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Meaney</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Shevell</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sinclair</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Yager</surname>
              <given-names>J</given-names>
            </name>
            <collab>Canadian Pediatric Ischemic Stroke Study Group</collab>
          </person-group>
          <article-title>Cerebral sinovenous thrombosis in children</article-title>
          <source>N Engl J Med</source>
          <year>2011</year>
          <volume>345</volume>
          <issue>6</issue>
          <fpage>417</fpage>
          <lpage>423</lpage>
          <pub-id pub-id-type="pmid">11496852</pub-id>
        </element-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hashmi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wasay</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Caring for cerebral venous sinus thrombosis in
children</article-title>
          <source>J Emerg Trauma Shock</source>
          <year>2011</year>
          <volume>4</volume>
          <issue>3</issue>
          <fpage>389</fpage>
          <lpage>394</lpage>
          <pub-id pub-id-type="pmid">21887032</pub-id>
        </element-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fluss</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Geary</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>deVeber</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Cerebral sinovenous thrombosis and idiopathic nephrotic syndrome in
childhood: report of four new cases and review of the literature</article-title>
          <source>Eur J Pediat</source>
          <year>2006</year>
          <volume>165</volume>
          <issue>10</issue>
          <fpage>709</fpage>
          <lpage>716</lpage>
        </element-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jackson</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Porcher</surname>
              <given-names>FK</given-names>
            </name>
            <name>
              <surname>Zapton</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Losek</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Cerebral sinovenous thrombosis in children: diagnosis and
treatment</article-title>
          <source>Pediatr Emerg Care</source>
          <year>2011</year>
          <volume>27</volume>
          <issue>9</issue>
          <fpage>874</fpage>
          <lpage>880</lpage>
          <comment>quiz 881-3</comment>
          <pub-id pub-id-type="pmid">21926891</pub-id>
        </element-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S&#xE9;bire</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tabarki</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Saunders</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Leroy</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Liesner</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Saint-Martin</surname>
              <given-names>C</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Cerebral venous sinus thrombosis in children: risk factors,
presentation, diagnosis and outcome</article-title>
          <source>Brain</source>
          <year>2005</year>
          <volume>128</volume>
          <issue-part>Pt 3</issue-part>
          <fpage>477</fpage>
          <lpage>489</lpage>
          <pub-id pub-id-type="pmid">15699061</pub-id>
        </element-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heller</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Heinecke</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Junker</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kn&#xF6;fler</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kosch</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kurnik</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Schobess</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>von Eckardstein</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Str&#xE4;ter</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zieger</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Nowak-G&#xF6;ttl</surname>
              <given-names>U</given-names>
            </name>
            <collab>Childhood Stroke Study Group</collab>
          </person-group>
          <article-title>Cerebral venous thrombosis in children: a multifactorial
origin</article-title>
          <source>Circulation</source>
          <year>2013</year>
          <volume>108</volume>
          <issue>11</issue>
          <fpage>1362</fpage>
          <lpage>1367</lpage>
          <pub-id pub-id-type="pmid">12939214</pub-id>
        </element-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grunt</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wingeier</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wehrli</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Boltshauser</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Capone</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fluss</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gubser-Mercati</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Jeannet</surname>
              <given-names>PY</given-names>
            </name>
            <name>
              <surname>Keller</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Marcoz</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Schmitt-Mechelke</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Weissert</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Steinlin</surname>
              <given-names>M</given-names>
            </name>
            <collab>Swiss Neuropaediatric Stroke Registry</collab>
          </person-group>
          <article-title>Cerebral sinus venous thrombosis in Swiss children</article-title>
          <source>Dev Med Child Neurol</source>
          <year>2010</year>
          <volume>52</volume>
          <issue>12</issue>
          <fpage>1145</fpage>
          <lpage>1150</lpage>
          <pub-id pub-id-type="pmid">20573178</pub-id>
        </element-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kenet</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Waldman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lubetsky</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kornbrut</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Khalil</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Koren</surname>
              <given-names>A</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Paediatric cerebral sinus vein thrombosis. A multi-center,
case-controlled study</article-title>
          <source>Thromb Haemost</source>
          <year>2004</year>
          <volume>92</volume>
          <issue>4</issue>
          <fpage>713</fpage>
          <lpage>718</lpage>
          <pub-id pub-id-type="pmid">15467900</pub-id>
        </element-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gasparetto</surname>
              <given-names>EL</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Trombose venosa cerebral</article-title>
          <source>Radiol Bras</source>
          <year>2006</year>
          <volume>39</volume>
          <issue>5</issue>
          <fpage>III</fpage>
        </element-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Monteiro</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Lins</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Miranda</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Miranda</surname>
              <given-names>LE</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Diagn&#xF3;stico por imagem e aspectos cl&#xED;nicos
da trombose venosa cerebral em rec&#xE9;m-natos a termo sem dano cerebral:
revis&#xE3;o em 10 anos</article-title>
          <source>Radiol Bras</source>
          <year>2010</year>
          <volume>43</volume>
          <issue>3</issue>
          <fpage>149</fpage>
          <lpage>153</lpage>
        </element-citation>
      </ref>
      <ref id="r20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dlamini</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Billinghurst</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kirkham</surname>
              <given-names>FJ</given-names>
            </name>
          </person-group>
          <article-title>Cerebral venous sinus (sinovenous) thrombosis in
children</article-title>
          <source>Neurosurg Clin N Am</source>
          <year>2010</year>
          <volume>21</volume>
          <issue>3</issue>
          <fpage>511</fpage>
          <lpage>527</lpage>
          <pub-id pub-id-type="pmid">20561500</pub-id>
        </element-citation>
      </ref>
      <ref id="r21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ichord</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Outcome in childhood cerebral venous thrombosis--new
insights</article-title>
          <source>Nat Clin Pract Neurol</source>
          <year>2008</year>
          <volume>4</volume>
          <issue>1</issue>
          <fpage>16</fpage>
          <lpage>17</lpage>
          <pub-id pub-id-type="pmid">18043594</pub-id>
        </element-citation>
      </ref>
      <ref id="r22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kenet</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kirkham</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Niederstadt</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Heinecke</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Saunders</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Stoll</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Brenner</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bidlingmaier</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Heller</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kn&#xF6;fler</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Schobess</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zieger</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>S&#xE9;bire</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Nowak-G&#xF6;ttl</surname>
              <given-names>U</given-names>
            </name>
            <collab>European Thromboses Study Group</collab>
          </person-group>
          <article-title>Risk factors for recurrent venous thromboembolism in the European
collaborative paediatric database on cerebral venous thrombosis: a multicentre
cohort study</article-title>
          <source>Lancet Neurol</source>
          <year>2007</year>
          <volume>6</volume>
          <issue>7</issue>
          <fpage>595</fpage>
          <lpage>603</lpage>
          <pub-id pub-id-type="pmid">17560171</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
